Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06429748 · ClinicalTrials.gov registry record · NA
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
A NA study of Neurologic Symptoms, sponsored by Neuronetics.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06429748 is a NA study of Neurologic Symptoms that is active but no longer recruiting, run by Neuronetics. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06429748, a NA study of Neurologic Symptoms, is active but no longer recruiting, sponsored by Neuronetics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.
Conditions Studied
Interventions
- DEVICE rTMS
Study Locations (1)
North Carolina
- Charlotte Skin and Laser - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-05-15 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06429748
The ClinicalTrials.gov registry entry for NCT06429748 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neuronetics, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurologic Symptoms appearing as the primary indexed condition, and to 1 intervention - of which rTMS is the first listed.
NCT06429748 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT06429748 about?
NCT06429748 is a clinical study titled "Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation". A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.
What is the current status of trial NCT06429748?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-05-15. Estimated completion is 2027-12-30.
What conditions does trial NCT06429748 study?
This clinical trial studies the following conditions: Neurologic Symptoms.
What interventions are being tested in trial NCT06429748?
The interventions under investigation include: rTMS (DEVICE).
Who is sponsoring clinical trial NCT06429748?
This trial is sponsored by Neuronetics, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06429748 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.